Results
|
561.
|
|
|
562.
|
|
|
563.
|
The InR/Akt/TORC1 Growth-Promoting Signaling Negatively Regulates JAK/STAT Activity and Migratory Cell Fate during Morphogenesis. [electronic resource] by
- Kang, Di
- Wang, Dou
- Xu, Jianbing
- Quan, Chao
- Guo, Xuan
- Wang, Heng
- Luo, Jun
- Yang, Zhongzhou
- Chen, Shuai
- Chen, Jiong
Producer: 20180529
In:
Developmental cell vol. 44
Availability: No items available.
|
|
564.
|
|
|
565.
|
Roles of paxillin family members in adhesion and ECM degradation coupling at invadosomes. [electronic resource] by
- Petropoulos, Christos
- Oddou, Christiane
- Emadali, Anouk
- Hiriart-Bryant, Edwige
- Boyault, Cyril
- Faurobert, Eva
- Vande Pol, Scott
- Kim-Kaneyama, Joo-Ri
- Kraut, Alexandra
- Coute, Yohann
- Block, Marc
- Albiges-Rizo, Corinne
- Destaing, Olivier
Producer: 20170529
In:
The Journal of cell biology vol. 213
Availability: No items available.
|
|
566.
|
|
|
567.
|
|
|
568.
|
|
|
569.
|
Chimeric G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient Induction of Cardiomyocytes from Mouse Induced Pluripotent Stem Cells. [electronic resource] by
- Tsukamoto, Tasuku
- Sogo, Takahiro
- Ueyama, Tomoe
- Nakao, Shu
- Harada, Yukihiro
- Ihara, Dai
- Akagi, Yuka
- Kida, Yasuyuki S
- Hasegawa, Koji
- Nagamune, Teruyuki
- Kawahara, Masahiro
- Kawamura, Teruhisa
Producer: 20201022
In:
Biotechnology journal vol. 15
Availability: No items available.
|
|
570.
|
Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation. [electronic resource] by
- Moriya, Kunihiko
- Suzuki, Tasuku
- Uchida, Nao
- Nakano, Tomohiro
- Katayama, Saori
- Irie, Masahiro
- Rikiishi, Takeshi
- Niizuma, Hidetaka
- Okada, Satoshi
- Imai, Kohsuke
- Sasahara, Yoji
- Kure, Shigeo
Producer: 20201029
In:
International journal of hematology vol. 112
Availability: No items available.
|
|
571.
|
|
|
572.
|
|
|
573.
|
|
|
574.
|
|
|
575.
|
|
|
576.
|
Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis. [electronic resource] by
- Cervantes, Francisco
- Vannucchi, Alessandro M
- Kiladjian, Jean-Jacques
- Al-Ali, Haifa Kathrin
- Sirulnik, Andres
- Stalbovskaya, Viktoriya
- McQuitty, Mari
- Hunter, Deborah S
- Levy, Richard S
- Passamonti, Francesco
- Barbui, Tiziano
- Barosi, Giovanni
- Harrison, Claire N
- Knoops, Laurent
- Gisslinger, Heinz
Producer: 20140211
In:
Blood vol. 122
Availability: No items available.
|
|
577.
|
|
|
578.
|
|
|
579.
|
JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome. [electronic resource] by
- Del Bel, Kate L
- Ragotte, Robert J
- Saferali, Aabida
- Lee, Susan
- Vercauteren, Suzanne M
- Mostafavi, Sara A
- Schreiber, Richard A
- Prendiville, Julie S
- Phang, Min S
- Halparin, Jessica
- Au, Nicholas
- Dean, John M
- Priatel, John J
- Jewels, Emily
- Junker, Anne K
- Rogers, Paul C
- Seear, Michael
- McKinnon, Margaret L
- Turvey, Stuart E
Producer: 20190410
In:
The Journal of allergy and clinical immunology vol. 139
Availability: No items available.
|
|
580.
|
|